Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$140,337,319
+$45,319,226 QoQ
Shares Held
1,647,345
+14.3% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#16
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. CYTK ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
This page
|
1,647,345 | $140,337,319 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,337,319 | 1,647,345 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $95,018,093 | 1,441,634 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $87,735,202 | 1,380,787 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $77,319,483 | 1,406,832 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $45,568,467 | 1,379,191 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $58,167,626 | 1,447,316 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $69,218,840 | 1,471,489 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $70,205,729 | 1,329,654 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $69,507,140 | 1,282,893 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $77,923,056 | 1,111,440 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $88,163,517 | 1,055,977 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $31,617,796 | 1,073,245 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,860,241 | 1,099,333 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $35,574,449 | 1,010,925 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $46,314,716 | 1,010,797 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $48,079,403 | 992,351 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $38,176,755 | 971,666 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $35,513,808 | 964,787 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $46,005,942 | 1,009,345 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $36,095,254 | 1,009,940 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,961,007 | 907,580 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $18,844,808 | 810,181 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $17,402,354 | 837,457 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $19,007,311 | 877,936 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $18,746,750 | 795,365 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $9,117,300 | 773,308 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||